Suppr超能文献

根据性别、发病年龄和HLA - B51分型的韩国白塞病患者的临床表型

Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51.

作者信息

Ryu Hee Jung, Seo Mi Ryoung, Choi Hyo Jin, Baek Han Joo

机构信息

Department of Rheumatology, Gachon University Gil Medical Center, Incheon, Korea.

出版信息

Korean J Intern Med. 2018 Sep;33(5):1025-1031. doi: 10.3904/kjim.2016.202. Epub 2017 Jan 12.

Abstract

BACKGROUND/AIMS: The clinical manifestations of Behcet disease (BD) have been reported to differ according to country, region, and race. Gender, onset age, and human leukocyte antigen (HLA)-B51 have also been known as the factors that influence the clinical features of BD. The aim of this study is to investigate the clinical phenotypes of Korean patients who visited the rheumatology clinic with BD with respect to gender, onset age, and HLA-B51.

METHODS

Total 193 Korean patients (129 females and 64 males) fulfilling the international criteria for BD were retrospectively assessed.

RESULTS

The mean age at disease onset and disease duration of the BD patients were 32.2 ± 11.1 and 14.2 ± 9.3 years, retrospectively. Females suffered more frequently from genital ulcers (90.7% vs. 75.0%, p < 0.01), peripheral arthritis (67.4% vs. 43.8%, p < 0.01), and inf lammatory low back pain (38.8% vs. 23.4%, p = 0.03) than males, while skin involvement was more frequent in males than in females (90.6% vs. 75.2%, p = 0.01). The patients with late onset of BD (> 40 years) suffered from neurologic involvement (15.9% vs. 4.2%, p = 0.007) more frequently than those with early onset of BD. The patients with HLA-B51 showed earlier onset of disease than without HLA-B51 (28.3 ± 11.4 years vs. 33.8±11.6 years, p = 0.02) and the neurologic and gastrointestinal involvements were more frequent in the patients without HLA-B51 than with HLA-B51 (17.2% vs. 2.5%, p = 0.02 and 20.7% vs. 2.5%, p = 0.01, respectively).

CONCLUSION

The clinical phenotypes in Korean patients with BD may be influenced by gender, onset age and HLA-B51.

摘要

背景/目的:据报道,白塞病(BD)的临床表现因国家、地区和种族而异。性别、发病年龄和人类白细胞抗原(HLA)-B51也被认为是影响BD临床特征的因素。本研究旨在调查因BD就诊于风湿病门诊的韩国患者在性别、发病年龄和HLA - B51方面的临床表型。

方法

对符合BD国际标准的193例韩国患者(129例女性和64例男性)进行回顾性评估。

结果

回顾性分析显示,BD患者的平均发病年龄和病程分别为32.2±11.1岁和14.2±9.3岁。女性比男性更易出现生殖器溃疡(90.7%对75.0%,p<0.01)、外周关节炎(67.4%对43.8%,p<0.01)和炎性腰背痛(38.8%对23.4%,p = 0.03),而男性皮肤受累比女性更常见(90.6%对75.2%,p = 0.01)。BD晚发患者(>40岁)比早发患者更易出现神经受累(15.9%对4.2%,p = 0.007)。携带HLA - B51的患者发病早于未携带HLA - B51的患者(28.3±11.4岁对33.8±11.6岁,p = 0.02),未携带HLA - B51的患者神经和胃肠道受累比携带HLA - B51的患者更常见(分别为17.2%对2.5%,p = 0.02和20.7%对2.5%,p = 0.01)。

结论

韩国BD患者的临床表型可能受性别、发病年龄和HLA - B51影响。

相似文献

1
Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51.
Korean J Intern Med. 2018 Sep;33(5):1025-1031. doi: 10.3904/kjim.2016.202. Epub 2017 Jan 12.
2
The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Int J Rheum Dis. 2014 May;17(4):466-70. doi: 10.1111/1756-185X.12271. Epub 2014 Jan 16.
3
Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients.
Eur J Intern Med. 2012 Jun;23(4):347-9. doi: 10.1016/j.ejim.2011.12.011. Epub 2012 Jan 27.
4
HLA-B51 Impact on Clinical Symptoms in Behcet's Disease.
J Coll Physicians Surg Pak. 2022 Jul;32(7):904-908. doi: 10.29271/jcpsp.2022.07.904.
6
Primary association of HLA-B51 with Behçet's disease in Ireland.
Br J Ophthalmol. 1997 Aug;81(8):649-53. doi: 10.1136/bjo.81.8.649.
7
Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease.
J Korean Med Sci. 2002 Jun;17(3):366-70. doi: 10.3346/jkms.2002.17.3.366.
9
Human leukocyte antigen B27 and B51 double-positive Behçet uveitis.
Arch Ophthalmol. 2007 Oct;125(10):1375-80. doi: 10.1001/archopht.125.10.1375.
10
The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey.
Mod Rheumatol. 2020 Jul;30(4):708-714. doi: 10.1080/14397595.2019.1649103. Epub 2019 Aug 6.

引用本文的文献

1
Assessing disease phenotypes in Behçet's syndrome: insights from a multiple correspondence analysis.
Front Immunol. 2025 Jun 20;16:1605714. doi: 10.3389/fimmu.2025.1605714. eCollection 2025.
3
HLA-B5 prevalence in patients with spondyloarthritis and impact on disease phenotype: a multicentric case-control study.
Rheumatology (Oxford). 2025 Apr 1;64(4):1835-1843. doi: 10.1093/rheumatology/keae366.
5
Epidemiologic and Etiological Features of Korean Patients With Behçet's Disease.
J Rheum Dis. 2021 Oct 1;28(4):183-191. doi: 10.4078/jrd.2021.28.4.183.
8
Past and Present Behçet's Disease Animal Models.
Curr Drug Targets. 2020;21(16):1652-1663. doi: 10.2174/1389450121666200719010425.
9
Behçet's disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature.
Clin Rheumatol. 2019 Sep;38(9):2565-2575. doi: 10.1007/s10067-019-04570-w. Epub 2019 May 22.

本文引用的文献

2
HLA-B*51 the primary risk in Behçet disease.
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8706-7. doi: 10.1073/pnas.1407307111. Epub 2014 May 29.
3
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.
J Neurol. 2014 Sep;261(9):1662-76. doi: 10.1007/s00415-013-7209-3. Epub 2013 Dec 24.
5
Epidemiology of Behçet disease.
Ocul Immunol Inflamm. 2012 Oct;20(5):324-35. doi: 10.3109/09273948.2012.723112.
6
Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients.
Eur J Intern Med. 2012 Jun;23(4):347-9. doi: 10.1016/j.ejim.2011.12.011. Epub 2012 Jan 27.
7
Demographic, clinical, and ocular features in patients with late-onset Behçet disease.
Ocul Immunol Inflamm. 2012 Apr;20(2):119-24. doi: 10.3109/09273948.2012.655882.
9
Late-onset Behçet's disease: demographic, clinical, and ocular features.
Graefes Arch Clin Exp Ophthalmol. 2010 Sep;248(9):1325-30. doi: 10.1007/s00417-010-1399-5. Epub 2010 May 7.
10
Validation of the International Criteria for Behçet's disease (ICBD) in Iran.
Int J Rheum Dis. 2010 Feb 1;13(1):55-60. doi: 10.1111/j.1756-185X.2009.01455.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验